MAGHNIE, MOHAMAD
 Distribuzione geografica
Continente #
EU - Europa 28.554
AS - Asia 3.572
NA - Nord America 3.415
Continente sconosciuto - Info sul continente non disponibili 437
SA - Sud America 286
AF - Africa 68
OC - Oceania 4
Totale 36.336
Nazione #
IT - Italia 28.040
US - Stati Uniti d'America 3.189
SG - Singapore 1.410
CN - Cina 895
VN - Vietnam 516
BD - Bangladesh 384
FR - Francia 235
BR - Brasile 150
HK - Hong Kong 127
CA - Canada 95
FI - Finlandia 61
DE - Germania 46
AR - Argentina 45
JP - Giappone 41
MX - Messico 36
NL - Olanda 35
GB - Regno Unito 30
CO - Colombia 28
EC - Ecuador 28
ID - Indonesia 28
CH - Svizzera 27
IN - India 24
JM - Giamaica 17
RU - Federazione Russa 17
IQ - Iraq 16
PK - Pakistan 16
CR - Costa Rica 14
PH - Filippine 14
VE - Venezuela 13
TR - Turchia 12
NI - Nicaragua 11
EG - Egitto 10
JO - Giordania 9
MA - Marocco 9
MY - Malesia 9
TH - Thailandia 9
TT - Trinidad e Tobago 9
ZA - Sudafrica 9
CL - Cile 8
ES - Italia 8
PR - Porto Rico 8
UA - Ucraina 8
GT - Guatemala 7
KR - Corea 7
SV - El Salvador 7
HN - Honduras 6
IE - Irlanda 6
IL - Israele 6
NP - Nepal 6
OM - Oman 6
PL - Polonia 6
RO - Romania 6
TN - Tunisia 6
UZ - Uzbekistan 6
DZ - Algeria 5
KE - Kenya 5
SN - Senegal 5
AU - Australia 4
IR - Iran 4
PE - Perù 4
PY - Paraguay 4
RS - Serbia 4
SA - Arabia Saudita 4
SC - Seychelles 4
AZ - Azerbaigian 3
BE - Belgio 3
BO - Bolivia 3
BS - Bahamas 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
LT - Lituania 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
CG - Congo 2
CY - Cipro 2
ET - Etiopia 2
GP - Guadalupe 2
HR - Croazia 2
KG - Kirghizistan 2
KW - Kuwait 2
LB - Libano 2
MQ - Martinica 2
NG - Nigeria 2
PS - Palestinian Territory 2
QA - Qatar 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
AG - Antigua e Barbuda 1
AL - Albania 1
BB - Barbados 1
BH - Bahrain 1
BJ - Benin 1
BY - Bielorussia 1
BZ - Belize 1
CD - Congo 1
CM - Camerun 1
GD - Grenada 1
GE - Georgia 1
Totale 35.884
Città #
Genova 15.559
Genoa 7.705
Rapallo 2.260
Vado Ligure 1.962
San Jose 819
Singapore 691
Ashburn 421
Lauterbourg 217
Beijing 165
Ho Chi Minh City 159
New York 143
Hanoi 121
Hong Kong 119
Council Bluffs 86
Milan 78
Los Angeles 68
Santa Clara 64
Helsinki 59
Bordighera 58
Chicago 42
Rome 42
Buffalo 37
Dallas 37
Tokyo 34
Boardman 32
Frankfurt am Main 31
Turin 28
Philadelphia 25
Phoenix 25
Zurich 25
Da Nang 23
Tianjin 22
Montreal 21
Naples 21
Newark 21
Atlanta 20
Mexico City 20
Haiphong 18
San Francisco 18
Washington 18
Houston 17
Orem 16
Toronto 16
São Paulo 14
Amsterdam 13
Bologna 13
Miami 13
Florence 12
Can Tho 11
Managua 11
Piscataway 11
San José 11
Brooklyn 10
Des Moines 10
Guayaquil 10
Kingston 10
Quito 10
Bari 9
Charlotte 9
The Bronx 9
Baghdad 8
Detroit 8
Jacksonville 8
Orlando 8
Alexandria 7
Boston 7
Cardiff 7
Cleveland 7
Columbus 7
Hải Dương 7
Istanbul 7
Kuala Lumpur 7
Las Vegas 7
Queens 7
Secaucus 7
Shanghai 7
Augusta 6
Baton Rouge 6
Belo Horizonte 6
Biên Hòa 6
Bogotá 6
Brescia 6
Cairo 6
Caracas 6
Denver 6
Guangzhou 6
London 6
Medellín 6
Palermo 6
Rochester 6
Springfield 6
Tampa 6
Warren 6
Warsaw 6
Albuquerque 5
Amman 5
Baltimore 5
Bangkok 5
City of London 5
Dakar 5
Totale 31.803
Nome #
Blood Cell Mitochondrial DNA Content and Premature Ovarian Aging. 597
Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism--pathogenesis, diagnosis and treatment. 327
Adult height in patients with permanent growth hormone deficiency with and without multiple pituitary hormone deficiencies 299
Age- and sex-matched reference curves for serum collagen type I C-telopeptides and bone alkaline phosphatase in children and adolescents: An alternative multivariate statistical analysis approach 246
A longitudinal printo study on growth and puberty in juvenile systemic lupus erythematosus. 245
Characteristics of a nationwide cohort of patients presenting with Isolated Hypogonadotropic Hypogonadism (IHH) 224
A "hot spot" in the Pit-1 gene responsible for combined pituitary hormone deficiency: clinical and molecular correlates. 210
A large-scale association study to assess the impact of known variants of the human INHA gene on premature ovarian failure. 209
Classical and non-classical causes of GH deficiency in the paediatric age 207
A novel pathogenic MYH3 mutation in a child with Sheldon–Hall syndrome and vertebral fusions 204
Clinical Manifestations and Metabolic Outcomes of Seven Adults with Silver-Russell Syndrome 200
X-linked agammaglobulinemia and isolated growth hormone deficiency. 198
Early-onset central diabetes insipidus is associated with de novo arginine vasopressin-neurophysin II or Wolfram syndrome 1 gene mutations. 198
Current perspective on the pathogenesis of central diabetes insipidus 196
A case of multiple intestinal atresias, brain anomalies, mental retardation, growth hormone deficiency and clitoris hypertrophy. 196
Management of diabetes insipidus and adipsia in the child. 192
Recombinant Human GH Replacement Therapy in Children with Pseudohypoparathyroidism Type Ia: First Study on the Effect on Growth. 184
Gut Microbiota in T1DM-Onset Pediatric Patients: Machine-Learning Algorithms to Classify Microorganisms as Disease Linked 184
Involvement of hormonal circadian secretion in the growth of HIV-infected children. 180
Cut-off limits of the peak GH response to stimulation tests for the diagnosis of GH deficiency in children and adolescents: Study in patients with organic GHD 180
Safety Outcomes during Pediatric GH Therapy: Final Results from the Prospective GeNeSIS Observational Program 180
Accuracy of Glucagon Testing Across Transition in Young Adults with Childhood-Onset Growth Hormone Deficiency 177
Idiopathic central diabetes insipidus is associated with abnormal blood supply to the posterior pituitary gland caused by vascular impairment of the inferior hypophyseal artery system. 177
A multi-method approach to the molecular diagnosis of overt and borderline 11p15.5 defects underlying Silver-€“Russell and Beckwith-€“Wiedemann syndromes 177
Central adrenal insufficiency in children and adolescents 177
X-linked hypophosphatemic rickets: an Italian experts' opinion survey 177
Pituitary gland imaging and outcome. 177
19q13.11 cryptic deletion: description of two new cases and indication for a role of WTIP haploinsufficiency in hypospadias. 175
Glucokinase mutations in pediatric patients with impaired fasting glucose 173
Adherence in children with growth hormone deficiency treated with r-hGH and the easypod™ device 171
Growth Hormone Deficiency in the Transition Age 171
Posterior pituitary (PP) evaluation in patients with anterior pituitary defect associated with ectopic PP and septo-optic dysplasia. 170
Contribution of LHX4 mutations to pituitary deficits in a cohort of 417 unrelated patients 170
Predictors of renal complications in pediatric patients with type 1 diabetes mellitus: A prospective cohort study 170
Prevalence and correlates of adherence in children and adolescents treated with growth hormone: A multicenter Italian study 166
Summary of Expert Opinion on the Management of Children With Chronic Kidney Disease and Growth Failure With Human Growth Hormone 165
Role of MRI T2-DRIVE in the assessment of pituitary stalk abnormalities without gadolinium in pituitary diseases 163
Cognitive and White Matter Microstructure Development in Congenital Hypothyroidism and Familial Thyroid Disorders 163
Central diabetes insipidus in children and young adults. 161
JAG1 loss-of-function variations as a novel predisposing event in the pathogenesis of congenital thyroid defects 161
Relationships between neuroradiological and clinical features in apparently idiopathic hypopituitarism. 159
Antipituitary antibodies in patients with pituitary abnormalities and hormonal deficiency. 159
Organization and regional distribution of centers for the management of children and adolescents with diabetes in Italy 159
Highly conserved non-coding sequences and the 18q critical region for short stature: a common mechanism of disease? 159
Central diabetes insipidus in children and young adults: etiological diagnosis and long-term outcome of idiopathic cases. 159
The growth hormone response to hexarelin in patients with different hypothalamic-pituitary abnormalities. 157
Accuracy and limitations of the growth hormone (GH) releasing hormone-arginine retesting in young adults with childhood-onset GH deficiency 157
A case of interference in testosterone, DHEA-S and progesterone measurements by second generation immunoassays 157
Adenosine Blood Level: A Biomarker of White Matter Damage in Very Low Birth Weight Infants 157
The use of neuroimaging for assessing disorders of pituitary development. 156
Endocrine pancreatic dysfunction in HIV-infected children: association with growth alterations. 156
Plasma total adiponectin levels in pediatrics: Reference intervals calculated as a continuous variable of age. 156
Growth Hormone Registry: A step forward in standard diagnostic practices in Italy. 155
Adult height in children with short stature and idiopathic delayed puberty after different management. 155
Neuroimaging in Growth hormone deficiency 154
Correlation between magnetic resonance imaging of posterior pituitary and neurohypophyseal function in children with diabetes insipidus. 154
Involvement of hypothalamus autoimmunity in patients with autoimmune hypopituitarism: role of antibodies to hypothalamic cells. 154
Assessment of serum IGF-I concentrations in the diagnosis of isolated childhood-onset GH deficiency: a proposal of the Italian Society for Pediatric Endocrinology and Diabetes (SIEDP/ISPED) 153
Midbrain-hindbrain involvement in septo-optic dysplasia. 153
Cognitive Profiles and Brain Volume Are Affected in Patients with Silver-Russell Syndrome 152
T2*-based MR imaging (gradient echo or susceptibility-weighted imaging) in midline and off-midline intracranial germ cell tumors: a pilot study 152
Correction to: Sleep disturbances in craniopharyngioma: a challenging diagnosis (Journal of Neurology, (2021), 268, 11, (4362-4369), 10.1007/s00415-021-10794-1) 151
Dynamic endocrine testing and magnetic resonance imaging in the long-term follow-up of childhood langerhans cell histiocytosis. 149
The advantage of measuring spontaneous growth hormone (GH) secretion compared with the insulin tolerance test in the diagnosis of GH deficiency in young adults. 148
Characterization of Two Novel Variants of the Steroidogenic Acute Regulatory Protein Identified in a Girl with Classic Lipoid Congenital Adrenal Hyperplasia 148
Familial ROBO1 deletion associated with ectopic posterior pituitary, duplication of the pituitary stalk and anterior pituitary hypoplasia 147
Organ- and non-organ-specific auto-antibodies in children with hypopituitarism on growth hormone therapy. 146
Cross-sectional reference data for phalangeal quantitative ultrasound from early childhood to young-adulthood according to gender, age, skeletal growth, and pubertal development 146
GH response to ghrelin in subjects with congenital GH deficiency: evidence that ghrelin action requires hypothalamic-pituitary connections 146
Comparison of clinical-radiological and molecular findings in hypochondroplasia. 145
Is growth hormone treatment in young children safe for the heart? 144
Pituitary stalk thickening on MRI: when is the best time to re-scan and how long should we continue re-scanning for? 144
Validation of the Italian Quality of Life in Short Stature Youth (QoLISSY) questionnaire 144
Effectiveness of growth hormone (GH) therapy in GH-deficient children and non-GH-deficient short children. 143
Bridging the gap: metabolic and endocrine care of patients during transition 143
Adult panhypopituritarism presenting as idiopathic growth hormone deficiency in childhood: really idiopathic? 142
Growth hormone treatment of adolescents with growth hormone deficiency (GHD) during the transition period: results of a survey among adult and paediatric endocrinologists from Italy. Endorsed by SIEDP/ISPED, AME, SIE, SIMA. 142
Pitfalls in the Diagnosis of Central Adrenal Insufficiency in Children. 142
Hypothalamic-pituitary dwarfism: comparison between MR imaging and CT findings. 142
Diagnosis of GH deficiency in the transition period: accuracy of insulin tolerance test and insulin-like growth factor-I measurement. 142
Efficacy and safety of growth hormone treatment in children with short stature: the Italian cohort of the GeNeSIS clinical study 142
Motor function improvement after intravenous pamidronate in osteoporosis pseudoglioma syndrome. 141
Growth hormone response to growth hormone-releasing hormone varies with the hypothalamic-pituitary abnormalities. 141
Impairment of the opioidergic control of luteinizing hormone secretion in Turner's syndrome: lack of effect of gonadal steroid therapy. 141
Hypothalamic-pituitary dysfunction in growth hormone-deficient patients with pituitary abnormalities. 141
Magnetic resonance imaging of the hypothalamus-pituitary unit in children suspected of hypopituitarism: who, how and when to investigate. 141
Shared Decision-Making in Growth Hormone Therapy-Implications for Patient Care 141
Autoimmunity, HLA, Gm and Km polymorphisms in Turner's syndrome. 140
The accuracy of magnetic resonance imaging and ultrasonography compared with surgical findings in the localization of the undescended testis. 140
Novel CNS malformations and skeletal anomalies in a patient with Beaulieu-boycott-Innes syndrome 140
PREDICTIVE ROLE OF THE IMMUNOSTAINING PATTERN OF IMMUNOFLUORESCENCE AND THE TITERS OF ANTIPITUITARY ANTIBODIES AT PRESENTATION FOR THE OCCURRENCE OF AUTOIMMUNE HYPOPITUITARISM IN PATIENTS WITH AUTOIMMUNE POLYENDOCRINE SYNDROMES OVER A FIVE-YEAR FOLLOW-UP.. 140
Results of early reevaluation of growth hormone secretion in short children with apparent growth hormone deficiency. 139
Disorders of salt and water balance in children. 138
Poland's syndrome associated with growth hormone deficiency. 138
Catch-up growth and height prognosis in early treated children with congenital hypopituitarism. 138
Case 1: An infant with water intoxication. 138
Characterizing short stature by insulin-like growth factor axis status and genetic associations: results from the prospective, cross-sectional, epidemiogenetic EPIGROW study. 138
Familial neurohypophyseal diabetes insipidus in 13 kindreds and 2 novel mutations in the vasopressin gene 137
Hypogonadism in a patient with balanced X/18 translocation and pituitary hormone deficiency. 136
GERMLINE PROKINETICIN RECEPTOR 2 (PROKR2) VARIANTS ASSOCIATED WITH CENTRAL HYPOGONADISM CAUSE DIFFERENTAL MODULATION OF DISTINCT INTRACELLULAR PATHWAYS. 136
Totale 16.910
Categoria #
all - tutte 121.682
article - articoli 116.654
book - libri 0
conference - conferenze 347
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.681
Totale 243.364


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.381 0 0 183 201 134 147 169 696 114 267 84 386
2022/20232.746 289 167 53 271 401 519 6 236 486 23 260 35
2023/20242.007 75 227 483 198 123 245 131 99 67 58 79 222
2024/20254.947 122 398 125 377 588 520 469 687 217 300 542 602
2025/20269.200 1.052 225 642 667 1.094 804 1.327 440 727 839 552 831
2026/20271.565 864 382 319 0 0 0 0 0 0 0 0 0
Totale 36.336